McKesson, US58155Q1031

McKesson stock gains as earnings guidance supports valuation

Published on 09/23/2026 at 11:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

McKesson stock traded at USD 896.22 on September 22, 2026, up 1.10 percent. August results showed revenue up 7.7 percent and EPS above consensus.

Mitarbeiter sortieren unbeschriftete Pakete in einem großen Pharma-Logistiklager mit Regalen
Fotorealistisches Bild zeigt McKesson Corporation ISIN US58155Q1031 als Pharmagroßhändler in modernem Distributionslager mit vielen Mitarbeitern, Illustration mit AI erstellt.

McKesson Corporation stock closed at USD 896.22 on the NYSE on September 22, 2026, up 1.10 percent from the prior close. The move leaves the shares USD 102.78 below the 52-week high of USD 999.00 and USD 182.22 above the 52-week low of USD 714.00.

Guidance supports the valuation

The operating figures provide the main support for the valuation. According to MarketBeat on September 23, 2026, McKesson reported USD 105.38 billion in revenue for the quarter announced on August 5, 2026, compared with USD 103.88 billion expected by analysts.

The revenue result was 7.7 percent above the comparable quarter a year earlier. Adjusted earnings per share reached USD 9.93, beating the USD 9.56 consensus by USD 0.37, while the prior-year figure was USD 8.26, according to MarketBeat.

EPS outlook reaches USD 45

Management guidance gives the market a forward benchmark. McKesson set fiscal 2027 adjusted EPS guidance at USD 44.20 to USD 45.00, representing growth of 13 percent to 15 percent, as reported by Ad-hoc-News on September 22, 2026.

That outlook matters because the latest quarterly EPS of USD 9.93 already exceeded consensus by USD 0.37. The comparison between 7.7 percent revenue growth and the 13 percent to 15 percent fiscal 2027 EPS growth range points to earnings expansion outpacing sales growth, although the reported net margin was 1.12 percent in the latest quarter, according to MarketBeat.

Stock remains below yearly high

At USD 896.22 on September 22, 2026, the stock was 10.29 percent below its 52-week high of USD 999.00 and 25.52 percent above its 52-week low of USD 714.00. The session volume was 120,517 shares, versus average volume of 950,548 shares, so the 1.10 percent gain occurred on turnover below the recent average.

Market capitalization stood at USD 104.49 billion on September 22, 2026. The combination of a USD 44.20 to USD 45.00 fiscal 2027 EPS range and a latest quarterly EPS result of USD 9.93 gives investors two dated reference points for assessing whether the valuation can move closer to the average analyst target of USD 973.44, reported by Ad-hoc-News on September 22, 2026.

McKesson stock closes at USD 896.22

McKesson Corporation stock closed at USD 896.22 on the NYSE on September 22, 2026, with the quote dated to the last completed trading session. The 7.7 percent year-over-year revenue increase, USD 9.93 quarterly EPS and USD 44.20 to USD 45.00 fiscal 2027 guidance remain the central quantified reference points.

McKesson Corporation stock data

  • Company: McKesson Corporation
  • ISIN: US58155Q1031
  • Ticker: MCK
  • Trading venue: NYSE
  • Price (as of September 22, 2026): USD 896.22
  • Market capitalization: USD 104.49 billion (as of September 22, 2026)
  • Sector / Industry: Health Care / Health Care Providers and Services
  • Index membership: S&P 500

More news and analyses on McKesson stock

Disclaimer...

en | US58155Q1031 | MCKESSON | boerse | 70165205 | bgmi